Hyaline vascular Castleman's disease: A case report and brief review of the literature

Netherlands Journal of Medicine

Volumn 60, Issue 11, 2002, Pages 444-447

  van den Berge, M ^a   Pauwels, P ^a   Jakimowicz, J J ^a   Creemers, G J ^a  

^a CATHARINA HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

HYALIN; INTERLEUKIN 6;

ABDOMINAL PAIN; ADULT; ANGIOFOLLICULAR LYMPH NODE HYPERPLASIA; ARTICLE; CASE REPORT; CELL TYPE; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; FOLLICULAR DENDRITIC CELL; HEARTBURN; HERPES VIRUS INFECTION; HISTOPATHOLOGY; HUMAN; HUMAN HERPESVIRUS 8; HUMAN TISSUE; NAUSEA; STOMACH BIOPSY; BLOOD; IMMUNOLOGY; KAPOSI SARCOMA; PATHOLOGY; REVIEW; VIROLOGY;

ADULT; FEMALE; GIANT LYMPH NODE HYPERPLASIA; HERPESVIRUS 8, HUMAN; HUMANS; INTERLEUKIN-6; SARCOMA, KAPOSI; TOMOGRAPHY, X-RAY COMPUTED;

EID: 0037514493     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (29)

1. Castleman B, Iverson L, Menendez VP. Localized mediastinal lymph node hyperplasia. Cancer 1956;9:822-30.
2. Flendrig JA, Schillings PM. Benign giant lympboma: the clinical signs and symptoms. Folia Medica Neerlandica 1969;12:119-20.
3. Keller AR, Hochholzer L, Castleman B. Hyaline-vascular and plasma cell types of giant lymph node hyperplasia of the mediastinum and other localisations. Cancer 1972;29:670-83.
4. Gaba AR, Stein RS, Sweet DL, Variakojis D. Multicentric giant lymph node hyperplasia. Am J Clin Pathol 1978;69:86-90.
5. Frizzera G. Castleman's disease and related disorders. Semin Diag Pathol 1988;5:346-64.
6. Chronowski GM, Ha CS, Wilder RB, et al. Treatment of unicentric and multicentric Castleman disease and the role of radiotherapy. Cancer 2001;92(3):670-6.
7. Peterson BA, Frizzera G. Multicentric Castleman's disease. Semin Oncol 1993;20:636-47.
8. Herrada J, Cabanillas F, Rice L, Manning J, Pugh W. The clinical behavior of localized and multicentric Castleman disease. Ann Intern Med 1998;128:657-62.
9. Mishicot N, Sasai M, Shima Y, et al. Improvement in Castleman's disease by humanized anti-interleukin-6 receptor antibody therapy. Blood 2000;95:56-61.
10. Repetto L, Jaiprakash MP, Selby PJ, Gusterson BA, Williams HJ, McElwain TJ. Aggressive angiofollicular lymph node hyperplasis (Castleman's disease) treated with high dose melphalan and autologous bone marrow transplantation. Hem Oncol 1986;4:213-7.
11. Andres E, Maloisel F. Interferon-alpha as first-line therapy for treatment of multicentric Castleman's disease. Ann Oncol 2000;11:613-4.
12. Oksenhendler E, Duarte M, Soulier J, et al Multicentric Castleman's disease in HIV infection: a clinical and pathological study of 20 patients. AIDS 1996;10:61-7.
13. Danon AD, Krishnan J, Frizzera G. Morpho-immunophenotypic diversity of Castleman's disease, hyaline-vascular type: with emphasis on a stromalrich variant and a new pathogenetic hypothesis. Virchows Arch 1993;423:369-82.
14. Nguyen DT, Diamond LW, Hangman ML, et al. Castleman's disease. Differences in follicular dendrite network in the hyaline vascular and plasma cell variants. Histopathology 1994;24:437-43.
15. Ruco LP, Gearing AJH, Pigott R, et al. Expression of ICAM-1, VCAM-1 and ELAM-1 in angiofolicular lymph node hyperplasia (Castleman's disease): evidence for dysplasia of follicular dendritic reticulum cells. Histopathology 1991;19:523-8.
16. Taylor GB, Smeeton IW. Cytologic demonstration of 'dysplastic follicular dendritic cells' in a case of hyaline-vascular Castleman's disease. Diagn Cytopathol 2000;22:230-4.
17. Chan JKC, Tsang WYW, Ng CS. Follicular dendritic cell tumor and vascular neoplasm complicating hyaline-vascular Castleman's disease. Am J Surg Pathol 1994;18:517-25.
18. Lin O, Frizzera G. Angiomyoid and follicular dendritic cell proliferative lesions in Castleman's disease of hyaline-vascular type: a study of 10 cases. Am J Surg Pathol 1997;21:1295-306.
19. Perez-Ordonez B, Rosai J. Follicular dendritic cell tumor: review of the entity. Semin Diag Pathol 1998;15:144-54.
20. Pauwels P, Dal Cin P, Vlasveld LT, et al. A chromosomal abnormality in hyaline vascular Castleman's disease. Am J Surg Pathol 2000;24:882-8.
21. Cokelaere K, Debiec-Rychter M, Wolf-Peeters C de, et al. Hyaline vascular Castleman's disease with HMGIC rearrangement in follicular dendritic cells: molecular evidence of mesenchymal tumorigenesis. Am J Surg Pathol 2002;26:662-9.
22. Yoshizaki K, Matsuda T, Nishimoto N, et al. Pathogenic significance of interleukine-6 (IL-6/BSF-2) in Castleman's disease. Blood 1989;74:1360-7.
23. Hsu SM, Waldron JA, Xsie SS, Barlogie B. Expression of interleukin-6 in Castleman's disease. Hum Pathol 1993;24:833-9.
24. Soulier J, Grollet L, Oksenhendler E, et al. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood 1995;86:1276-80.
25. Mori Y, Nishimoto N, Ohno M, et al. Human herpes virus 8-encoded interleukin-6 homologue (viral IL-6) induces endogenous human IL-6 secretion. J Med Virol 2000;61:332-5.
26. Oksenhendler E, Carcelain G, Aoki Y, et al. High levels of human herpesvirus 8 viral load, human interleukin-6, interleukin-10, and C reactive protein correlate with exacerbation of multicentric Castleman disease in HIV-infected patients. Blood 2000;96:2069-73.
27. Larroche C, Cacoub P, Soulier J, et al. Castleman's disease and lymphoma: report of eight cases in HIV-negative patients and literature review. Am J Hematol 2002;69:119-26.
28. Oksenhendler E, Boulanger E, Galicier L, et al. High incidence of Kaposi sarcoma-associated herpesvirus-related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease. Blood 2002;99:2331-6.
29. Frizzera G, Peterson BA, Bayrd ED, Goldman A. A systemic lymphoproliferative disorder with morphologic features of Castleman's disease: clinical findings and clinicopathologic correlations in 15 patients. J Clin Oncol 1985;3:1202-12.